OP-055 The First Real-World Experience of the New Oral Anticoagulants in Turkey

OP-055 The First Real-World Experience of the New Oral Anticoagulants in Turkey

According to this data, both drugs has no superiority over each other in terms of the protection from thromboembolism and hemorrhagic complications. All Cause Death 10 5 n.s. Thromboembolism 0 1 (cerebrovascular accident) n.s. Intracranial hemorrhage 1 0 n.s. Subdural Hematoma 0 1 n.s. Gastrointesti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2016-06, Vol.117, p.S22-S23
Hauptverfasser: Yiginer, Omer, Erdal, Emrah, Acar, Gurkan, Cay, Serkan, Ergelen, Mehmet, Cetin, Hande, Tezcan, Mehmet, Dogan, Mehmet, Un, Haluk, Ozcelik, Fatih, Degirmencioglu, Gokhan, Tokatli, Alptug
Format: Artikel
Sprache:eng
Schlagworte:
Anticoagulants
Cardiovascular
Coagulation
Hemorrhage
Thromboembolism
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:According to this data, both drugs has no superiority over each other in terms of the protection from thromboembolism and hemorrhagic complications. All Cause Death 10 5 n.s. Thromboembolism 0 1 (cerebrovascular accident) n.s. Intracranial hemorrhage 1 0 n.s. Subdural Hematoma 0 1 n.s. Gastrointestinal Hemorrhage 7 4 n.s. Minor Hemorrhage 10 14 n.s. The Clinical Events During the Usage of New Oral Anticoagulants
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2016.04.095